Company / Cash per Share
Matinas BioPharma Holdings, Inc. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.68
FY2024
5-year range
$0.03 / $1.68
FY2020-FY2024
Trend
+5232.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +5232% YoY in FY2024, a notable deviation from the 9-year average annual change of +585%.
Based on SEC 10-K filings.
1.68 in FY2024 with a 5-year CAGR of +53.7%.
Improved from $0.10 to $1.68 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +151.7%
- 5-Year CAGR
- +53.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cash per share increased 5232.4% year-over-year.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.68 | +5232.4% |
| FY2023 | $0.03 | -67.7% |
| FY2022 | $0.10 | -7.5% |
| FY2021 | $0.11 | +37.9% |
| FY2020 | $0.08 | -61.1% |
| FY2019 | $0.20 | +150.1% |
| FY2018 | $0.08 | +10.9% |
| FY2017 | $0.07 | -1.7% |
| FY2016 | $0.07 | -28.2% |
| FY2015 | $0.10 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026